Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moxidex Otic Solution vs Moxifloxacin Otic Solution in AOMT
2018-000640-26Phase 3
- Sponsor
- Alcon Inc.
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of moxifloxacin + dexamethasone in acute otitis media (AOM) (2 arms), sponsored by Alcon Inc. Primary endpoint: Time to cessation of otorrhea.
02
Drugs
moxifloxacin + dexamethasone
03
Conditions
acute otitis media (AOM)
Beyond the preview
Go deeper on 2018-000640-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000640-26.